Assessment of magnetic resonance imaging (MRI) after neoadjuvant chemoradiation therapy (nCRT) is essential in rectal cancer staging and treatment planning. However. when predicting the pathologic complete response (pCR) after nCRT for rectal cancer. existing works either rely on simple quantitative evaluation based on radiomics features or partially analyze multi-parametric MRI. https://www.markymarkscott.com/product-category/one-united-all-in-one-multi-benefit-trea/